Milestone Scientific to Present at the Edgewater Research Investor Conference
September 26 2007 - 8:30AM
PR Newswire (US)
LIVINGSTON, N.J., Sept. 26 /PRNewswire-FirstCall/ -- Milestone
Scientific, Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today announced that
senior officials have been invited to present at the upcoming
EdgeWater Research Fall 2007 Small/Micro Cap Conference to be held
in Tucson, Arizona. WHO: Leonard Osser, Chairman and CEO, Milestone
Scientific Joe Martin, CEO, Milestone Medical WHEN: Wednesday,
October 10, 2007 at 8:50 AM MDT WHERE: Loews Ventana Canyon Resort
7000 North Resort Drive Tucson, AZ 85750 EdgeWater Research
Partners, LLC is an independent micro cap equities research company
representing the research of David Lavigne. EdgeWater follows a
number of undiscovered small and micro cap stocks through both
individual research and its monthly publication, The EdgeWater
Micro Monthly. EdgeWater's research is distributed to its
subscriber base, and is also available on a piece by piece basis on
the Company's website, http://www.edgewaterresearch.com/. About
Milestone Scientific, Inc. Headquartered in Livingston, New Jersey,
Milestone Scientific is engaged in pioneering proprietary, highly
innovative technological solutions for the medical and dental
markets. Central to the Company's IP platform and product
development strategy is its patented CompuFlo(TM) technology for
the improved and painless delivery of local anesthetic.
Specifically, CompuFlo is a computer-controlled, pressure sensitive
infusion, perfusion, suffusion and aspiration technology, which
provides real-time readouts of pressures, fluid densities and flow
rates, enabling the advanced delivery and removal of a wide array
of fluids. The STA(TM) System, a computer-controlled local
anesthesia delivery system which uses this technology provides
dentists with audible and visual signals as to in-tissue pressure.
Milestone's existing painless injection systems are currently sold
in 25 countries. For more information on these and other innovative
Milestone products, please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement: This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2006. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist 407-585-1080 or via email at DATASOURCE: Milestone
Scientific, Inc. CONTACT: Dodi Handy or Daniel Conway, both for
Milestone Scientific, Inc., +1-407-585-1080, Web site:
http://www.milesci.com/ http://www.edgewaterresearch.com/
Copyright